Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium Study. (Q46032981)
Jump to navigation
Jump to search
scientific article published in January 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium Study. |
scientific article published in January 2006 |
Statements
1 reference
Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium Study. (English)
1 reference
Katherine K Matthay
1 reference
Jessica C Tan
1 reference
Judith G Villablanca
1 reference
Gregory A Yanik
1 reference
Janet Veatch
1 reference
Benjamin Franc
1 reference
Eilish Twomey
1 reference
Biljana Horn
1 reference
C Patrick Reynolds
1 reference
Susan Groshen
1 reference
Robert C Seeger
1 reference
John M Maris
1 reference
1 January 2006
1 reference
1 reference
24
1 reference
500-506
1 reference
3
1 reference
Identifiers
1 reference
1 reference